All In Biotech

Drug Trial Radar · NCT02110147

Open-Label Study of Uridine Triacetate in Pediatric Patients With Hereditary Orotic Aciduria

Last checked: Nov 20, 2026Latest source record: Jul 31, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

4

Actual

Start

Apr 2014

Primary completion

Dec 2014

Study completion Sep 8, 2016

Sponsor

Lead sponsor
Wellstat TherapeuticsIndustry
Sponsor type
Industry
First posted
Apr 10, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 6 months, up to 19 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This protocol has two parts - the Main Study which is 42 days in length and the Treatment Extension which allows the patients who complete the Main Study to continue receiving treatment with uridine triacetate. The purpose of this study is to replace oral administration of uridine with oral administration of uridine triacetate in patients with hereditary orotic aciduria who have received (or would reasonably be expected to receive) clinical benefit from treatment with exogenous uridine. It is also to document the continued clinical benefit of exogenous uridine when patients are switched from oral administration of uridine to oral administration of uridine triacetate.

Conditions

  • Hereditary Orotic Aciduria

Interventions

  • uridine triacetateDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Patients With Stable Predetermined Principal Hematologic ParametersTime frame: Days 28 and 42

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Children's Hospital of Michigan - Specialty Center Detroit

    Detroit, Michigan

  • Children's Hospital of Pittsburgh of UPMC

    Pittsburgh, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.